NCT00171236已完成3 期
Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 84
- 试验地点
- 1
研究概览
简要总结
The purpose of the study is to assess the safety and efficacy of fluvastatin in children diagnosed with heterozygous familial hypercholesterolemia
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 10 Years 至 16 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •10-16 years old Heterozygous familial hypercholesterolemia
排除标准
- •Homozygous familial hypercholesterolemia Pregnant or lactating females Major surgery during the six month prior study
- •Other protocol defined inclusion and exclusion criteria may apply
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsAntiphospholipid SyndromeNCT00674297Hospital for Special Surgery, New York41
已完成
4 期
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)InfluenzaNCT01691326Sanofi Pasteur, a Sanofi Company60
已完成
1 期
8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial HypercholesterolemiaPediatric Heterozygous HypercholesterolemiaNCT00739999Pfizer's Upjohn has merged with Mylan to form Viatris Inc.39
进行中（未招募）
早期 1 期
Fimepinostat in Treating Brain Tumors in Children and Young AdultsDiffuse Intrinsic Pontine GliomaRecurrent Anaplastic AstrocytomaRecurrent Malignant GliomaRecurrent MedulloblastomaRecurrent GlioblastomaNCT03893487Sabine Mueller, MD, PhD30
已完成
4 期
Fluvastatin in Adults With Dislipidemia With History of Muscle ProblemsDyslipidemiaNCT00125125Novartis218